Press Release

Teva news, press releases, and media contact information

Printer Friendly Version View printer-friendly version
<< Back
Teva to Present at the 35th Annual J.P. Morgan Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Jan. 6, 2017-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 35th Annual J.P. Morgan Healthcare Conference. Teva’s management will present on Monday, January 9, 2017 at 9:30 AM PST.

What:

  Teva Presentation at the 35th Annual J.P. Morgan Healthcare Conference
 

When:

Monday, January 9, 2017 at 9:30 AM PST
 

Where:

www.ir.tevapharm.com

 

How:

Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.
 

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2015 were $19.7 billion. For more information, visit www.tevapharm.com.

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
IR:
Kevin C. Mannix, 215-591-8912
United States
or
Ran Meir, 215-591-3033
United States
or
Tomer Amitai, 972 (3) 926-7656
Israel
or
PR:
Iris Beck Codner, 972 (3) 926-7246
Israel
or
Denise Bradley, 215-591-8974
United States